Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) 10-Year ROIIC % : 138.02% (As of Jun. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Clinuvel Pharmaceuticals's 10-Year ROIIC % for the quarter that ended in Jun. 2023 was 138.02%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Clinuvel Pharmaceuticals's 10-Year ROIIC % or its related term are showing as below:

CLVLF's 10-Year ROIIC % is ranked better than
88.11% of 1362 companies
in the Biotechnology industry
Industry Median: -33.26 vs CLVLF: 138.02

Clinuvel Pharmaceuticals 10-Year ROIIC % Historical Data

The historical data trend for Clinuvel Pharmaceuticals's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals 10-Year ROIIC % Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

10-Year ROIIC %

Get a 7-Day Free Trial

1,067.90

326.50

193.45

172.61

138.02

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
10-Year ROIIC %	Get a 7-Day Free Trial															-	172.61	-	138.02	-

Competitive Comparison of Clinuvel Pharmaceuticals's 10-Year ROIIC %

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's 10-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's 10-Year ROIIC % falls into.

Clinuvel Pharmaceuticals 10-Year ROIIC % Calculation

Clinuvel Pharmaceuticals's 10-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

10-Year ROIIC %	=	10-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	10-Year Incremental Invested Capital^**
	=	( 19.8757285 (Jun. 2023) - -7.82 (Jun. 2013) )	/	( 19.631 (Jun. 2023) - 1.693 (Jun. 2013) )
	=	27.6957285	/	17.938
	=	154.40%^***

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Clinuvel Pharmaceuticals (OTCPK:CLVLF) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Clinuvel Pharmaceuticals 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » 10-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.